Literature DB >> 16830321

Should ovarian cryopreservation be offered to girls with cancer.

Michael Weintraub1, Eitan Gross, Avishag Kadari, Vardit Ravitsky, Anat Safran, Neri Laufer, Ariel Revel.   

Abstract

Current therapy of childhood cancer makes long-term survival a realistic outcome for most patients. However, some treatment regimens entail a significant risk of infertility. No established method for preservation of female fertility is currently available. Ovarian cryopreservation is an experimental technology that is being offered with increasing frequency to women undergoing cancer therapy. It has not yet been reported in children and adolescent girls. The aim of this review is to stimulate discussion on the possibility of performing ovarian cryopreservation in pre-menarcheal girls in advance of therapies that may induce ovarian failure. We present a multi-disciplinary discussion of the risks and benefits associated with the procedure and propose guidelines for its implementation. We propose that all girls about to receive treatment that has a high risk for infertility be offered consultation about the possibility of ovarian cryopreservation. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 16830321     DOI: 10.1002/pbc.20946

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Engineering the follicle microenvironment.

Authors:  Erin R West; Lonnie D Shea; Teresa K Woodruff
Journal:  Semin Reprod Med       Date:  2007-07       Impact factor: 1.303

Review 2.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

3.  Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix?

Authors:  Hyacinth N Browne; Kimberly S Moon; Sunni L Mumford; Enrique F Schisterman; Alan H Decherney; James H Segars; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2011-05-07       Impact factor: 7.329

4.  Fertility preservation in young cancer patients.

Authors:  Ariel Revel; Shoshana Revel-Vilk
Journal:  J Hum Reprod Sci       Date:  2010-01

Review 5.  Preservation of female fertility during cancer treatment.

Authors:  Atsushi Imai; Tatsuro Furui; Akio Yamamoto
Journal:  Reprod Med Biol       Date:  2008-02-01

Review 6.  Preserving female fertility following cancer treatment: current options and future possibilities.

Authors:  Erin R West; Mary B Zelinski; Laxmi A Kondapalli; Clarisa Gracia; Jeffrey Chang; Christos Coutifaris; John Critser; Richard L Stouffer; Lonnie D Shea; Teresa K Woodruff
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

7.  Fertility preservation in girls.

Authors:  Jennia Michaeli; Michael Weintraub; Eitan Gross; Yehuda Ginosar; Vardit Ravitsky; Einat Eizenman; Eduardo Mitrani; Meital Lebovich; Neri Laufer; Stephen Kennedy; Ariel Revel
Journal:  Obstet Gynecol Int       Date:  2012-02-16

8.  Cryopreservation of ovarian tissue in pediatric patients.

Authors:  R Fabbri; R Vicenti; M Macciocca; G Pasquinelli; M Lima; I Parazza; V Magnani; S Venturoli
Journal:  Obstet Gynecol Int       Date:  2012-02-13

Review 9.  Orthotopic and heterotopic ovarian tissue transplantation.

Authors:  I Demeestere; P Simon; S Emiliani; A Delbaere; Y Englert
Journal:  Hum Reprod Update       Date:  2009-05-27       Impact factor: 15.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.